vaccine as quickly as possible, the Trump administration has agreed to invest more than half a billion in tax dollars in ApiJect Systems America, a young company.
Its injector is not approved by federal health authorities and the company hasn't yet set up a factory to manufacture the devices.The commitment to ApiJect dwarfs the other needle orders the government has placed with a major manufacturer and two other small companies.“The fact of this matter is, it would be crazy for people to just rely on us.
I would be the first to say it," said ApiJect CEO Jay Walker. “We should be America's backup at this point, but probably not its primary."Trump administration officials would not say why they are investing so heavily in ApiJect's.